Abstract: This paper explores potential genetic testing that could help doctors prescribe antidepressants that are more effective, with fewer side effects. Various methods are explored including metabolization of psychotropic drugs and levels of DNA methylation on CpG islands and the effectiveness of the GeneSight Psychotropic Genetic Panel. The findings suggest that doctors should utilize DNA tests more, and that scientists should do more research on the tests to increase their effectiveness.